Genomic Health, Inc. (GHDX) Tops Q1 EPS by 5c
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Price: $63.44 --0%
Financial Fact:
Product revenues: 244.92M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Product revenues: 244.92M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Genomic Health, Inc. (NASDAQ: GHDX) reported Q1 EPS of $0.02, $0.05 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $58.58 million versus the consensus estimate of $56.27 million.
For earnings history and earnings-related data on Genomic Health, Inc. (GHDX) click here.
For earnings history and earnings-related data on Genomic Health, Inc. (GHDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- Investing.com’s stocks of the week
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
